Uae Pharmaceutical Contract Manufacturing And Research Services Market
The pharmaceutical contract manufacturing and research services market in the UAE is expected to reach a projected revenue of US$ 2,859.2 million by 2030. A compound annual growth rate of 4.9% is expected of the UAE pharmaceutical contract manufacturing and research services market from 2024 to 2030.
UAE pharmaceutical contract manufacturing and research services market highlights
The UAE pharmaceutical contract manufacturing and research services market generated a revenue of USD 2,050.7 million in 2023 and is expected to reach USD 2,859.2 million by 2030.
The UAE market is expected to grow at a CAGR of 4.9% from 2024 to 2030.
In terms of segment, manufacturing was the largest revenue generating service in 2023.
Research is the most lucrative service segment registering the fastest growth during the forecast period.
Pharmaceutical contract manufacturing and research services market data book summary
Market revenue in 2023
USD 2,050.7 million
Market revenue in 2030
USD 2,859.2 million
Growth rate
4.9% (CAGR from 2023 to 2030)
Largest segment
Manufacturing
Fastest growing segment
Research
Historical data
2018 - 2022
Base year
2023
Forecast period
2024 - 2030
Quantitative units
Revenue in USD million
Market segmentation
Manufacturing, Research
Key market players worldwide
Catalent Inc, Pharmaceutical Product Development, AbbVie Inc, Baxter International Inc, Grifols SA Ordinary Shares - Class A, Dalton Pharma Services, Boehringer Ingelheim, Lonza Group Ltd
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
In Middle East & Africa, South Africa pharmaceutical contract manufacturing and research services market is projected to lead the regional market in terms of revenue in 2030.
South Africa is the fastest growing regional market in Middle East & Africa and is projected to reach USD 5,009.6 million by 2030.
The pharmaceutical contract manufacturing and research services market is growing in the country due to factors such as a supportive regulatory environment, infrastructure, and facilities provided by the country, and skilled workforce, and growing year-on-year investments in R&D in the UAE.
For example, in Abu Dhabi, the government has invested USD 1.09 billion in funds to boost R&D in 2020.
The country also has a decent healthcare structure and attractive tax benefits, which is expected to boost the market in the coming years.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Pharmaceutical Contract Manufacturing And Research Services Market will help companies and investors design strategic landscapes.
Manufacturing was the largest segment with a revenue share of 66.19% in 2023.
Horizon Databook has segmented the Uae pharmaceutical contract manufacturing and research services market based on manufacturing, research covering the revenue growth of each sub-segment from 2018 to 2030.
The pharmaceutical contract manufacturing and research services market is growing in the country due to factors such as a supportive regulatory environment, infrastructure, and facilities provided by the country, and skilled workforce, and growing year-on-year investments in R&D in the UAE.
For example, in Abu Dhabi, the government has invested USD 1.09 billion in funds to boost R&D in 2020.
The country also has a decent healthcare structure and attractive tax benefits, which is expected to boost the market in the coming years.
Uae Pharmaceutical Contract Manufacturing And Research Services Market Service Outlook (Revenue, USD Million , 2018-2030)
Manufacturing
Research
Reasons to subscribe to pharmaceutical contract manufacturing market databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of pharmaceutical contract manufacturing market databook
Our clientele includes a mix of pharmaceutical contract manufacturing market companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE pharmaceutical contract manufacturing market, including forecasts for subscribers. This country databook contains high-level insights into UAE pharmaceutical contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Uae Pharmaceutical Contract Manufacturing And Research Services Market, 2018-2030 (US$M)